JAIME STEWART: Open Payments
NPI 1851997340 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 20 payments from 16 companies in 2025. Trend: 2023 $260 · 2024 $257 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Astellas Pharma US Inc | 1 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Verona Pharma, Inc. | 1 | $24 |
| Neos Therapeutics, LP | 1 | $24 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, Veozah, Ohtuvayre, Adzenys XR-ODT, Tlando, LEQVIO, Korlym.
Industry payments across OH — which companies pay providers there.
